Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
All people
Emmanouil V. Dermitzakis
Sort by Type
Date
Speaker
ePoster
P023
Patients satisfaction to triptans and to available oral and injectable medications (OnabotulinumtoxinA/anti-CGRP MAbs) for migraine prophylaxis. Results of a web-based survey
ePoster
P256
The effect of 9-months fremanezumab preventive treatment on the triptan response and on the incidence of triggers and prodromal symptoms in patients with HFEM
Further involvements
ePoster
P031
Reporting quality and risk of bias analysis of published RCTs assessing anti-CGRP monoclonal antibodies in migraine prophylaxis – a systematic review
ePoster
P023
Patients satisfaction to triptans and to available oral and injectable medications (OnabotulinumtoxinA/anti-CGRP MAbs) for migraine prophylaxis. Results of a web-based survey
ePoster
P146
Menopause and its impact on the effectiveness of fremanezumab for migraine prophylaxis: Post-hoc analysis of a prospective, real-world Greek registry
ePoster
P150
Effects of onabotulinumtoxinA on interictal burden and cutaneous allodynia of patients with chronic migraine
ePoster
P256
The effect of 9-months fremanezumab preventive treatment on the triptan response and on the incidence of triggers and prodromal symptoms in patients with HFEM
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy